ACAN
aggrecan
ACAN; aggrecan; AGC1; SEDK; AGCAN; CSPG1; MSK16; CSPGCP; aggrecan core protein; large aggregating proteoglycan; cartilage-specific proteoglycan core protein; chondroitin sulfate proteoglycan core protein 1;
BRCA1
breast cancer 1, early onset
BRCA1; breast cancer 1, early onset; breast cancer type 1 susceptibility protein; BRCA1/BRCA2 containing complex; subunit 1; BRCC1; PPP1R53; protein phosphatase 1; regulatory subunit 53; RNF53; RING finger protein 53; BRCA1/BRCA2-containing complex, subunit 1; protein phosphatase 1, regulatory subunit 53; breast and ovarian cancer susceptibility protein 1; breast and ovarian cancer sususceptibility protein 1; IRIS; PSCP; BRCAI; PNCA4; BROVCA1;
CA1
carbonic anhydrase I
CA1; carbonic anhydrase I; carbonic anhydrase 1; Car1; JW0122; CA 1; CA I; CA-I; CAB; CAH1_HUMAN; CAI; CAN; Car 1; Carbonate dehydratase I; Carbonic anhydrase B; Carbonic dehydratase; ECK0125; yadF; OTTHUMP00000227973; OTTHUMP00000227974; OTTHUMP00000227976; OTTHUMP00000227977; OTTHUMP00000227978; OTTHUMP00000227979; OTTHUMP00000227981; Car-1; AW555628;
GPC3
glypican 3
GPC3; glypican 3; SDYS; glypican-3; DGSX; glypican proteoglycan 3; OCI 5; SGB; SGBS; SGBS1; secreted glypican-3; intestinal protein OCI-5; heparan sulphate proteoglycan; MXR7; OCI-5; GTR2-2;
GPC4
glypican 4
GPC4; glypican 4; glypican-4; glypican proteoglycan 4; K glypican; dJ900E8.1 (glypican 4); K-glypican;
GPC5
glypican 5
GPC5; glypican 5; glypican-5; glypican proteoglycan 5; Glypican 5 precursor; GPC5_HUMAN; Secreted glypican-5; bA93M14.1; OTTHUMP00000018551;
HAPLN1
hyaluronan and proteoglycan link protein 1
HAPLN1; hyaluronan and proteoglycan link protein 1; cartilage linking protein 1 , CRTL1; Cartilage link protein; cartilage linking protein 1; CLP; CRTL1; Crtl1l; Hyaluronan and proteoglycan link protein 1 precursor; LP; Proteoglycan link protein; cartilage-link protein; cartilage-linking protein 1;
LUM
lumican
LUM; lumican; LDC; lumican proteoglycan; SLRR2D; Keratan sulfate proteoglycan lumican; KSPG Lumican; LUM_HUMAN; Lumican precursor; OTTHUMP00000242889;
MESDC2
mesoderm development candidate 2
MESDC2; mesoderm development candidate 2; LDLR chaperone MESD; BOCA; KIAA0081; MESD; mesoderm development protein; renal carcinoma antigen NY-REN-61;
MSH2
mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
MSH2; mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli); COCA1, mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1); DNA mismatch repair protein Msh2; HNPCC; HNPCC1; hMSH2; FCC1; COCA1; LCFS2;
Pigf
phosphatidylinositol glycan anchor biosynthesis, class F
PIGF; phosphatidylinositol glycan anchor biosynthesis, class F; phosphatidylinositol glycan, class F; phosphatidylinositol-glycan biosynthesis class F protein; PIG-F; GPI11 homolog; MGC32646; MGC33136;
PRG4
proteoglycan 4
PRG4; proteoglycan 4; CACP, proteoglycan 4, (megakaryocyte stimulating factor, articular superficial zone protein, camptodactyly, arthropathy, coxa vara, pericarditis syndrome); articular superficial zone protein; bG174L6.2; bG174L6.2 (MSF: megakaryocyte stimulating factor ); camptodactyly; arthropathy; coxa vara; pericarditis syndrome; FLJ32635; HAPO; Jacobs camptodactyly arthropathy pericarditis syndrome; JCAP; lubricin; megakaryocyte stimulating factor; MSF; SZP; Superficial zone proteoglycan; CACP; Camptodactyly arthropathy coxa vara pericarditis syndrome gene; Jacobs camptodactyly arthropathy pericarditis syndrome gene; PRG 4; Proteoglycan4; megakaryocyte-stimulating factor;
RCAN3
RCAN family member 3
RCAN3; RCAN family member 3; Down syndrome critical region gene 1 like 2 , DSCR1L2; calcipressin-3; Down syndrome candidate region 1 like 2; regulator of calcineurin 3; Down syndrome candidate region 1 like protein 2; Down syndrome candidate region 1-like protein 2; Down syndrome critical region gene 1 like 2; DSCR1L2; hRCN3; MCIP3; Myocyte enriched calcineurin interacting protein 3; Myocyte-enriched calcineurin-interacting protein 3; RCAN3_HUMAN; RCN3; Down syndrome candidate region 1-like 2; Down syndrome critical region gene 1-like 2;
SCAND1
SCAN domain containing 1
SCAND1; SCAN domain containing 1; SCAN domain-containing protein 1; RAZ1; SDP1; Leap1; Leucine rich domain interacting protein 1; Pgc2; PPAR gamma cofactor 2; Ppargc2; SCAN domain containing protein 1; SCAN related protein RAZ1; SCAN domain-containing 1; SCAN-related protein RAZ1;
SDC1
syndecan 1
SDC1; syndecan 1; syndecan-1; synstatin; Sstn; Synd; CD138; Synd1; syn-1; AA408134; AA409076;
SDC4
syndecan 4
SDC4; SYND4; syndecan 4; Syndecan 4; amphiglycan; ryudocan amphiglycan; ryudocan core protein; syndecan proteoglycan 4; syndecan 4 (amphiglycan, ryudocan);
SDCBP
syndecan binding protein (syntenin)
SDCBP; syndecan binding protein (syntenin); syntenin-1; SYCL; scaffold protein Pbp1; syndecan-binding protein 1; melanoma differentiation associated protein-9; melanoma differentiation-associated protein 9; pro-TGF-alpha cytoplasmic domain-interacting pro;
SNCG
synuclein, gamma (breast cancer-specific protein 1)
SNCG; synuclein, gamma (breast cancer-specific protein 1); SR; BCSG1; gamma-synuclein; persyn; synoretin; breast cancer-specific gene 1 protein;
TSSC1
tumor suppressing subtransferable candidate 1
TSSC1; tumor suppressing subtransferable candidate 1; protein TSSC1; Tumor suppressing subchromosomal transferable fragment; TSSC 1; Tumor suppressing STF cDNA 1 protein; Tumor suppressing subchromosomal transferable fragment candidate gene 1 protein; OTTHUMP00000115381; OTTHUMP00000199995; tumor-suppressing STF cDNA 1 protein; tumor-suppressing subchromosomal transferable fragment candidate gene 1 protein;
TSSC4
tumor suppressing subtransferable candidate 4
TSSC4; tumor suppressing subtransferable candidate 4; protein TSSC4; tumor-suppressing STF cDNA 4 protein; tumor-suppressing subchromosomal transferable fragment candidate gene 4 protein;
WHSC1
Wolf-Hirschhorn syndrome candidate 1
WHSC1; Wolf-Hirschhorn syndrome candidate 1; probable histone-lysine N-methyltransferase NSD2; MMSET; NSD2; FLJ23286; IL5 promoter REII region binding protein; KIAA1090; MGC176638; MMSET type II; Multiple myeloma SET domain containing protein type III; Multiple myeloma SET domain protein; Multiple myeloma SET domain-containing protein; NSD 2; NSD2_HUMAN; Nuclear SET domain-containing protein 2; Protein trithorax-5; REIIBP; Trithorax/ash1 related protein 5; TRX5; TRX5 protein; WHS; Wolf Hirschhorn syndrome candidate 1; Wolf Hirschhorn syndrome candidate 1 protein; Wolf-Hirschhorn syndrome candidate 1 protein; OTTHUMP00000159146; OTTHUMP00000220792; OTTHUMP00000220796; OTTHUMP00000220798; OTTHUMP00000220830; trithorax/ash1-related protein 5; IL5 promoter REII region-binding prote;
WHSC2
Wolf-Hirschhorn syndrome candidate 2
WHSC2; Wolf-Hirschhorn syndrome candidate 2; negative elongation factor A; NELF A; FLJ10442; FLJ25112; Negative elongation factor polypeptide A; NELFA; P/OKcl.15; P/OKcl15; WHSC 2; Wolf Hirschhorn syndrome candidate 2; Wolf Hirschhorn syndrome candidate 2 protein; wolf-Hirschhorn syndrome candidate 2 protein; NELF-A;
NF2
neurofibromin 2 (merlin)
NF2; neurofibromin 2 (merlin); merlin; neurofibromin 2 (bilateral acoustic neuroma); Moesin-ezrin-radixin-like protein; SCH; CAN; BANF; OTTHUMP00000199607; moesin-ezrin-radixin like; moesin-ezrin-radizin-like protein; neurofibromin-2; schwannomerlin; schwannomin; ACN; OTTHUMP00000028855; OTTHUMP00000199606; OTTHUMP00000199608; OTTHUMP00000199609; OTTHUMP00000199610; OTTHUMP00000199611; OTTHUMP00000199621; OTTHUMP00000199622;
WHSC1L1
Wolf-Hirschhorn syndrome candidate 1-like 1
WHSC1L1; Wolf-Hirschhorn syndrome candidate 1-like 1; histone-lysine N-methyltransferase NSD3; FLJ20353; NSD3; DKFZp667H044; Histone lysine N methyltransferase NSD3; MGC126766; MGC142029; NSD 3; Nuclear set domain containing 3; Nuclear SET domain containing protein 3; pp14328; Whistle; WHSC1 like protein 1; WHSC1L1 protein; Wolf Hirschhorn syndrome candidate 1 like 1; protein whistle; OTTHUMP00000228478; OTTHUMP00000228479; OTTHUMP00000228480; OTTHUMP00000228487; WHSC1-like protein 1; nuclear SET domain-containing protein 3; WHSC1-like 1 isoform 9 with methyltransferase activity to lysi;
ALS2CR8
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8
ALS2CR8; amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8; amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein; calcium response factor; CaRF; FLJ21579; NYD SP24; calcium-response factor; testis development;
ASPSCR1
alveolar soft part sarcoma chromosome region, candidate 1
ASPSCR1; alveolar soft part sarcoma chromosome region, candidate 1; tether containing UBX domain for GLUT4; ASPL; ASPS; UBX domain protein 9; UBXD9; UBXN9; UBX domain-containing protein 9; alveolar soft part sarcoma locus; renal cell carcinoma, papillary,;
BCAR1
breast cancer anti-estrogen resistance 1
BCAR1; breast cancer anti-estrogen resistance 1; CAS; CAS1; CASS1; CRKAS; P130Cas; breast cancer anti-estrogen resistance protein 1; Crk-associated substrate p130Cas; Cas scaffolding protein family member 1;
BCAR3
breast cancer anti-estrogen resistance 3
BCAR3; breast cancer anti-estrogen resistance 3; breast cancer anti-estrogen resistance protein 3; NSP2; SH2D3B; BCAR 3; Novel SH2 containing protein 2; SH2 domain containing protein 3B; Breast cancer anti estrogen resistance 3; Breast cancer anti estrogen resistance protein 3; Breast cancer antiestrogen resistance 3; dJ1033H22.2; dJ1033H22.2 breast cancer anti estrogen resistance 3; dJ1033H22.2 breast cancer antiestrogen resistance 3; KIAA0554; NSP 2; SH2 containing protein Nsp2; OTTHUMP00000011959; OTTHUMP00000011960; OTTHUMP00000011961; OTTHUMP00000011962; novel SH2-containing protein 2; SH2 domain-containing protein 3B; dJ1033H22.2 (breast cancer anti-estrogen resistance 3);
BGN
biglycan
BGN; biglycan; PGI; DSPG1; PG-S1; SLRR1A; biglycan proteoglycan; bone/cartilage proteoglycan I; bone/cartilage proteoglycan-I; small leucine-rich protein 1A; dermatan sulphate proteoglycan I;
BRMS1
breast cancer metastasis suppressor 1
BRMS1; breast cancer metastasis suppressor 1; breast cancer metastasis-suppressor 1; DKFZP564A063; AV003220; AW554636; MGC95128; OTTHUMP00000235056; OTTHUMP00000235057; OTTHUMP00000235060; OTTHUMP00000235062;
CNR1
Cnr1 cannabinoid receptor 1 (brain)
CNR1; cannabinoid receptor 1 (brain); cannabinoid receptor 1; brain-type cannabinoid receptor; striatal cannabinoid receptor type 1 protein; CB1; CB-R; CB1R;
CNR2
cannabinoid receptor 2 (macrophage)
CNR2; cannabinoid receptor 2 (macrophage); CB2; CX5; CB-2; cannabinoid receptor 2; testis-dominant CNR2 isoform CB2;
CSPG5
chondroitin sulfate proteoglycan 5 (neuroglycan C)
CSPG5; chondroitin sulfate proteoglycan 5 (neuroglycan C); chondroitin sulfate proteoglycan 5; NGC; Acidic leucine rich EGF like domain containing brain protein; Acidic leucine-rich EGF-like domain-containing brain protein; Caleb; CSPG5_HUMAN; MGC44034; Neuroglycan C; OTTHUMP00000164796; OTTHUMP00000164797; OTTHUMP00000210429;
CTAG2
cancer/testis antigen 2
CTAG2; cancer/testis antigen 2; CAMEL; cancer/testis antigen family 6; member 2a; member 2b; CT6.2a; CT6.2b; CTL recognized antigen on melanoma; ESO2; LAGE 1; LAGE 1a; LAGE 1a protein; LAGE 1b; LAGE1; MGC3803; MGC138724; Autoimmunogenic cancer/testis antigen NY ESO 2; Autoimmunogenic cancer/testis antigen NY-ESO-2; Cancer/testis antigen 6.2; CT 2; CT2; CT6.2; CTAG 2; CTAG2_HUMAN; ESO 2; L antigen family member 1; LAGE 2b; LAGE-1; LAGE2b; LAGE-1a protein; OTTHUMP00000026043; OTTHUMP00000026044; CTL-recognized antigen on melanoma; cancer/testis antigen family 6, member 2a; cancer/testis antigen family 6, member 2b; autoim;
DAG1
dystroglycan 1 (dystrophin-associated glycoprotein 1)
DAG1; dystroglycan 1 (dystrophin-associated glycoprotein 1); A3a; DAG; AGRNR; 156DAG; MDDGC7; MDDGC9; dystroglycan;
FRA10AC1
fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1
FRA10AC1; fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1; C10orf4, chromosome 10 open reading frame 4; protein FRA10AC1; Chromosome 10 open reading frame 4; F26C11.1 like; FRA10AC1 protein; Fragile site 10q23.3; PRO2972; Rare folic acid type fragile site FRA(10)(q23.3) candidate gene 1; OTTHUMP00000020120; rare folic acid-type fragile site, FRA(10)(q23.3), candidate gene 1; FRA10A; C10orf4; F26C11.1-like;
GLTSCR2
glioma tumor suppressor candidate region gene 2
GLTSCR2; glioma tumor suppressor candidate region gene 2; glioma tumor suppressor candidate region gene 2 protein; PICT 1; p60; PICT1; protein interacting with carboxyl terminus 1; PICT-1;
HAPLN4
hyaluronan and proteoglycan link protein 4
HAPLN4; hyaluronan and proteoglycan link protein 4; BRAL2; KIAA1926; Brain link protein 2; BRAL 2; HAPLN 4; HPLN4_HUMAN; Hyaluronan and proteoglycan link protein 4 precursor;
HIC1
hypermethylated in cancer 1
HIC1; hypermethylated in cancer 1; hic-1; ZBTB29; ZNF901; hypermethylated in cancer 1 protein; zinc finger and BTB domain-containing protein 29;
LEPRE1
leucine proline-enriched proteoglycan (leprecan) 1
LEPRE1; leucine proline-enriched proteoglycan (leprecan) 1; prolyl 3-hydroxylase 1; GROS1; growth suppressor 1; LEPRECAN; MGC117314; P3H1; prolyl 3 hydroxylase 1; leucine- and proline-enriched proteoglycan 1; OI8;
LEPREL4
leprecan-like 4
NO55; SC65; NOL55; synaptonemal complex protein SC65; OTTHUMP00000164758; leprecan-like protein 4; nucleolar autoantigen No55; nucleolar autoantigen (55kD); nucleolar autoantigen, 55kDa; LEPREL4; leprecan-like 4;
MCC
mutated in colorectal cancers
MCC; mutated in colorectal cancers; colorectal mutant cancer protein; DKFZp762O1615; FLJ38893; FLJ46755; MCC 1; MCC1; Protein MCC; OTTHUMP00000159017; OTTHUMP00000222860; OTTHUMP00000223206;
PIGO
phosphatidylinositol glycan anchor biosynthesis, class O
PIGO; phosphatidylinositol glycan anchor biosynthesis, class O; phosphatidylinositol glycan, class O; GPI ethanolamine phosphate transferase 3; DKFZp434M222; FLJ00135; MGC20536; MGC3079; FLJ00350; mFLJ00350; OTTHUMP00000021324; OTTHUMP00000021325; OTTMUSP00000007085; Phosphatidylinositol glycan anchor biosynthesis class O; Phosphatidylinositol glycan biosynthesis class O protein; Phosphatidylinositol glycan class O; PIG O; RP11-182N22.4; RP23-124L1.7; PIG-O; phosphatidylinositol-glycan biosynthesis class O protein;
SDCBP2
syndecan binding protein (syntenin) 2
SDCBP2; syndecan binding protein (syntenin) 2; syntenin-2; SITAC18; ST 2; MDA9; Melanoma differentiation associated gene 9; Pro TGF alpha cytoplasmic domain interacting protein 18; Syndecan binding protein 2; OTTHUMP00000029961; OTTHUMP00000029962; OTTHUMP00000029963; OTTHUMP00000029964; ST-2; SITAC;
SGCA
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
SGCA; sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein); ADL, sarcoglycan, alpha (50kD dystrophin associated glycoprotein); alpha-sarcoglycan; 50kD DAG; A2; adhalin; adhalin (limb girdle muscular dystrophy 2D); DMDA2; LGMD2D; Sarcoglycan; alpha (50kD dystrophin associated glycoprotein; adhalin); SCARMD1; 50DAG; 59kDa; ADL; DAG2; 50 DAG; 50 kDa dystrophin associated glycoprotein; 50 kDa dystrophin-associated glycoprotein; Alpha SG; Alpha-SG; Asg; Dystroglycan 2; Dystroglycan-2; sarcoglycan, alpha (dystrophin-associated glycoprotein); SGCA_HUMAN; OTTHUMP00000221051; OTTHUMP00000221052; OTTHUMP00000221053; 50-DAG;
SGCB
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
SGCB; sarcoglycan, beta (43kDa dystrophin-associated glycoprotein); LGMD2E, sarcoglycan, beta (43kD dystrophin associated glycoprotein); beta-sarcoglycan; A3b; SGC; 43DAG; beta-SG; 43 kDa dystrophin-associated glycoprotein; limb girdle muscular dystrophy;
ZSCAN18
zinc finger and SCAN domain containing 18
ZSCAN18; zinc finger and SCAN domain containing 18; zinc finger protein 447 , ZNF447; zinc finger and SCAN domain-containing protein 18; FLJ12895; Zinc finger protein 447; ZNF447;
ZSCAN20
zinc finger and SCAN domain containing 20
ZSCAN20; zinc finger and SCAN domain containing 20; zinc finger protein 31 , zinc finger protein 31 (KOX 29) , ZNF31, ZNF360; zinc finger and SCAN domain-containing protein 20; KOX29; ZFP 31; ZFP31; zinc finger protein 31 (KOX 29); Zinc finger protein 31; Zinc finger protein 360; Zinc finger protein KOX29; ZNF360; OTTHUMP00000004352; OTTHUMP00000179080; ZNF31; ZFP-31;
ZSCAN21
zinc finger and SCAN domain containing 21
ZSCAN21; zinc finger and SCAN domain containing 21; zinc finger protein 38 , zinc finger protein 38 (KOX 25) , ZNF38; zinc finger and SCAN domain-containing protein 21; DKFZp434L134; NY REN 21; Zipro1; DKFZp686H10254; NYREN21; Renal carcinoma antigen NY REN 21; ZFP38; Zinc finger and SCAN domain containing protein 21; zinc finger protein 38 (KOX 25); Zinc finger protein 38 homolog; zinc finger protein NY REN 21 antigen; ZNF38; zfp-38; OTTHUMP00000206179; OTTHUMP00000206945; renal carcinoma antigen NY-REN-21; zinc finger protein NY-REN-21 antigen; NY-REN-21;
PIGL
phosphatidylinositol glycan anchor biosynthesis, class L
PIGL; phosphatidylinositol glycan anchor biosynthesis, class L; phosphatidylinositol glycan, class L; N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase; N acetylglucosaminylphosphatidylinositol deacetylase; Phosphatidylinositol glycan anchor biosynthesis class L; Phosphatidylinositol glycan class L; Phosphatidylinositol-glycan biosynthesis class L protein; PIG-L; PIGL_HUMAN; N-acetylglucosaminylphosphatidylinositol deacetylase;
PIGS
phosphatidylinositol glycan anchor biosynthesis, class S
PIGS; phosphatidylinositol glycan anchor biosynthesis, class S; GPI transamidase component PIG-S; DKFZp686K20216; FLJ45226; GPI transamidase subunit; Phosphatidylinositol glycan anchor biosynthesis class S; Phosphatidylinositol glycan class S; Phosphatidylinositol-glycan biosynthesis class S protein; PIGS_HUMAN; phosphatidylinositol glycan, class S homolog; Gm393; Gm689; BC058979;
PGLYRP2
peptidoglycan recognition protein 2
PGLYRP2; peptidoglycan recognition protein 2; N-acetylmuramoyl-L-alanine amidase; N acetylmuramoyl L alanine amidase; peptidoglycan recognition protein L precursor; peptidoglycan recognition protein like; PGLYRPL; PGRP L; PGRPL; tagL; tagL alpha; tagl beta; TAGL like; Peptidoglycan recognition protein L; OTTHUMP00000198257; peptidoglycan recognition protein long; PGRP-L; HMFT0141; TAGL-like; tagl-beta; tagL-alpha;
GBE1
glucan (1,4-alpha-), branching enzyme 1
GBE1; glucan (1,4-alpha-), branching enzyme 1; 1,4-alpha-glucan-branching enzyme; Andersen disease; glycogen branching enzyme; glycogen storage disease type IV; 1; 1,4 alpha glucan branching enzyme; 4-alpha-glucan-branching enzyme; amylo (1,4 to 1,6) transglucosidase; amylo (1,4 to 1,6) transglycosylase; Brancher enzyme; GBE 1; GBE; gGlucan (1,4 alpha ), branching enzyme 1; GLGB_HUMAN; Glucan (1,4 alpha) branching enzyme; Glycogen-branching enzyme; OTTHUMP00000213788; OTTHUMP00000213833; amylo-(1,4 to 1,6) transglucosidase; amylo-(1,4 to 1,6) transglycosylase;
Pglyrp1
peptidoglycan recognition protein 1
PGLYRP1; peptidoglycan recognition protein 1; peptidoglycan recognition protein , PGLYRP, TNFSF3L; PGRP; PGRP S; PGRPS; TAG7; MGC126894; MGC126896; Peptidoglycan recognition protein; PGLYRP; PGRP-PEN; PGRP-S; TNFSF 3L; TNFSF3L; TNF superfamily, member 3 (LTB)-like (peptidoglycan recognition protein);
BRCA2
breast cancer 2, early onset
BRCA2; breast cancer 2, early onset; FACD, FANCD, FANCD1, Fanconi anemia, complementation group D1; breast cancer type 2 susceptibility protein; BRCA1/BRCA2 containing complex; subunit 2; BRCC2; FAD; FAD1; fanconi anemia group D1 protein; breast cancer 2;
CECR1
cat eye syndrome chromosome region, candidate 1
CECR1; cat eye syndrome chromosome region, candidate 1; IDGFL; adenosine deaminase CECR1; ADGF; Cat eye syndrome chromosome region candidate 1; Cat eye syndrome critical region protein 1; Cat eye syndrome critical region protein 1 precursor; CECR 1; adenosine deaminase 2; ADA2;
CSPG4
chondroitin sulfate proteoglycan 4
CSPG4; chondroitin sulfate proteoglycan 4; NG2; MCSP; MCSPG; MSK16; HMW-MAA; MEL-CSPG; chondroitin sulfate proteoglycan NG2; melanoma chondroitin sulfate proteoglycan; melanoma-associated chondroitin sulfate proteoglycan; chondroitin sulfate proteoglycan 4 (melanoma-associated);
DYX1C1
dyslexia susceptibility 1 candidate 1
DYX1C1; dyslexia susceptibility 1 candidate 1; dyslexia susceptibility 1 candidate gene 1 protein; EKN1; FLJ37882; RD; DYX1; DYXC1; MGC70618;
GPC1
glypican 1
GPC1; glypican 1; glypican-1; glypican; glypican proteoglycan 1; FLJ38078; glypican1; GPC 1; GPC1_HUMAN; Secreted glypican-1; OTTHUMP00000164497; OTTHUMP00000201548;
LDOC1
leucine zipper, down-regulated in cancer 1
LDOC1; leucine zipper, down-regulated in cancer 1; BCUR1; protein LDOC1; Mar7; Mart7; Breast cancer up regulated 1; Breast cancer upregulated 1; Gm366; Leucine zipper down regulated in cancer 1; Leucine zipper protein down regulated in cancer cells; RGD1565644; OTTHUMP00000024174; breast cancer, up-regulated 1; leucine zipper protein down-regulated in cancer cells;
PGLYRP3
peptidoglycan recognition protein 3
PGLYRP3; peptidoglycan recognition protein 3; peptidoglycan recognition protein I alpha precursor; PGLYRPIalpha; PGRP Ialpha; PGRPIA; PGRP-I-alpha; peptidoglycan recognition protein I alpha; peptidoglycan recognition protein I-alpha; peptidoglycan recogni;
PGLYRP4
peptidoglycan recognition protein 4
PGLYRP4; peptidoglycan recognition protein 4; peptidoglycan recognition protein I beta precursor; PGLYRPIbeta; PGRP Ibeta; PGRPIB; SBBI67; PGRP-I-beta; OTTHUMP00000035127; OTTHUMP00000035128; peptidoglycan recognition protein I beta; peptidoglycan recognition protein I-beta; peptidoglycan recognition protein-I-beta; peptidoglycan recognition protein intermediate; PGRP-Ibeta;
PIGB
phosphatidylinositol glycan anchor biosynthesis, class B
PIGB;phosphatidylinositol glycan anchor biosynthesis, class B;phosphatidylinositol glycan, class B;GPI mannosyltransferase 3;PIG-B;GPI-MT-III;GPI mannosyltransferase III;phosphatidylinositol-glycan biosynthesis class B protein;MGC21236;
PIGC
phosphatidylinositol glycan anchor biosynthesis, class C
PIGC; phosphatidylinositol glycan anchor biosynthesis, class C; phosphatidylinositol glycan, class C; phosphatidylinositol N-acetylglucosaminyltransferase subunit C; GPI2; Phosphatidylinositol glycan biosynthesis class C protein; Phosphatidylinositol N acetylglucosaminyltransferase subunit C; PIG-C; OTTHUMP00000032652; phosphatidylinositol-glycan biosynthesis class C protein; phosphatidylinositol-glycan biosynthesis, class C protein;
PIGH
phosphatidylinositol glycan anchor biosynthesis, class H
PIGH; phosphatidylinositol glycan anchor biosynthesis, class H; phosphatidylinositol glycan, class H; phosphatidylinositol N-acetylglucosaminyltransferase subunit H; GPI H; GPIH; Phosphatidylinositol glycan anchor biosynthesis class H; Phosphatidylinositol glycan biosynthesis class H protein; Phosphatidylinositol glycan class H; Phosphatidylinositol N acetylglucosaminyltransferase subunit H; Phosphatidylinositol-glycan biosynthesis class H protein; PIG H; PIG-H; PIGH_HUMAN; OTTHUMP00000246879; phosphatidylinositol-glycan biosynthesis, class H protein; GPI-H;
PIGP
phosphatidylinositol glycan anchor biosynthesis, class P
PIGP; phosphatidylinositol glycan anchor biosynthesis, class P; Down syndrome critical region gene 5 , DSCR5, phosphatidylinositol glycan, class P; phosphatidylinositol N-acetylglucosaminyltransferase subunit P; DCRC; DSRC; phosphatidylinositol n acetylglucosaminyltranferase subunit; DCRC S; Down syndrome critical region gene 5; Down syndrome critical region protein 5; Down syndrome critical region protein C; DSCR 5; DSCR5; DSCRC; Phosphatidylinositol glycan anchor biosynthesis class P; Phosphatidylinositol glycan biosynthesis class P; Phosphatidylinositol glycan biosynthesis class P protein; Phosphatidylinositol glycan class P; Phosphatidylinositol N acetylglucosaminyltransferase subunit P; PIG-P; OTTHUMP00000109075; OTTHUMP00000109076; OTTHUMP00000109077; OTTHUMP00000109078; OTTHUMP00000109079; phosphatidylinositol glycan, class P; Down syndrome cri; DCRC-S;
PIGQ
phosphatidylinositol glycan anchor biosynthesis, class Q
PIGQ; phosphatidylinositol glycan anchor biosynthesis, class Q; phosphatidylinositol glycan, class Q; phosphatidylinositol N-acetylglucosaminyltransferase subunit Q; GPI1; hGPI1; PIG-Q; N-acetylglucosamyl transferase component GPI1; N-acetylglucosaminyl t;
PIGT
phosphatidyl inositol glycan class T
PIGT;phosphatidyl inositol glycan class T;phosphatidylinositol glycan, class T;GPI transamidase subunit;Q969N2;phosphatidylinositol glycan anchor biosynthesis, class T;OTTHUMP00000031110;OTTHUMP00000031112;Phosphatidylinositol-glycan biosynthesis class T protein;GPI transamidase component PIG-T;FLJ41596;MGC8909;neurotrophin-regulated neuronal development-associated protein;NDAP;
SDC2
syndecan 2
SDC2; syndecan 2; HSPG; CD362; HSPG1; SYND2; syndecan-2; fibroglycan; syndecan proteoglycan 2; heparan sulfate proteoglycan core protein; cell surface-associated heparan sulfate proteoglycan 1; heparan sulfate proteoglycan 1, cell surface-associated;
SGCD
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein); sarcoglycan, delta (35kD dystrophin associated glycoprotein); delta-sarcoglycan; CMD1L; DAGD; LGMD2F; 35 kDa dystrophin associated glycoprotein; 35 kDa dystrophin-associated glycoprotein; 35DAG; Delta-SG; Dystrophin associated glycoprotein delta sarcoglycan; MGC22567; Sarcoglycan delta (35 kDa dystrophin associated glycoprotein); SG delta; SGCD_HUMAN; SGCDP; SGD; OTTHUMP00000223946; OTTHUMP00000223947; OTTHUMP00000223961; placental delta sarcoglycan; 35kD dystrophin-associated glycoprotein; dystrophin associated glycoprotein, delta sarcoglycan; SG-delta;
SGCG
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
SGCG; sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein); DMDA1, LGMD2C, MAM, sarcoglycan, gamma (35kD dystrophin associated glycoprotein); gamma-sarcoglycan; 35kD dystrophin associated glycoprotein; A4; DAGA4; DMDA; gamma sarcoglycan; limb girdle muscular dystrophy 2C (Duchenne like muscular dystrophy; autosomal recessive); Maghrebian myopathy (autosomal recessive); MGC130048; SCARMD2; SCG3; TYPE; 35 kDa dystrophin associated glycoprotein; Gamma SG; 35 kDa dystrophin-associated glycoprotein; 35DAG; DMDA1; Gamma-SG; LGMD2C; MAM; Sarcoglycan gamma; SGCG_HUMAN; OTTHUMP00000018112; 35kD dystrophin-associated glycoprotein;
SPOCK3
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3
SPOCK3; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3; testican-3; testican 3; HSAJ1454; OTTHUMP00000219853; OTTHUMP00000219854; OTTHUMP00000219857; OTTHUMP00000219858; OTTHUMP00000219862; OTTHUMP00000219864; OTTHUMP00000219865; OTTHUMP00000219866; OTTHUMP00000219867; OTTHUMP00000219868; Sparc/osteonectin, cwcv and kazal like domains proteoglycan (testican) 3; SPARC/osteonectin, CWCV, and Kazal like domains proteoglycan 3; TES 3; TICN3; TES-3;
VCAN
versican
VCAN; versican; WGN; ERVR; GHAP; PG-M; WGN1; CSPG2; versican core protein; versican proteoglycan; large fibroblast proteoglycan; glial hyaluronate-binding protein; chondroitin sulfate proteoglycan 2; chondroitin sulfate proteoglycan core protein 2;
ZKSCAN1
zinc finger with KRAB and SCAN domains 1
ZKSCAN1; zinc finger with KRAB and SCAN domains 1; zinc finger protein 36 (KOX 18) , ZNF36, ZNF139; zinc finger protein with KRAB and SCAN domains 1; KOX18; PHZ 37; MGC138429; MGC63357; Zinc finger protein 139; Zinc finger protein 36 (KOX 18); Zinc finger protein 36; Zinc finger protein KOX18; ZKSC1_HUMAN; ZNF139; ZNF36; PHZ-37; 9130423L19Rik;
ZKSCAN5
zinc finger with KRAB and SCAN domains 5
ZKSCAN5; zinc finger with KRAB and SCAN domains 5; ZFP95, zinc finger protein 95 homolog (mouse) , zinc finger protein homologous to Zfp95 in mouse; zinc finger protein with KRAB and SCAN domains 5; ZNF914; FLJ39233; HGNC:12867; KIAA1015; MGC33710; Zfp 95; ZFP95; Zinc finger protein 95 homolog; zfp-95; zinc finger protein homologous to Zfp95 in mouse;
ZSCAN4
zinc finger and SCAN domain containing 4
ZSCAN4; zinc finger and SCAN domain containing 4; ZNF494; zinc finger and SCAN domain-containing protein 4; zinc finger protein 494;
C1orf57
NTPCR nucleoside-triphosphatase, cancer-related
C1orf57; FLJ11383; MGC13186; HCR-NTPase; RP4-659I19.2; RP4-678E16.2; cancer-related nucleoside-triphosphatase; OTTHUMP00000035941; OTTHUMP00000035942; human cancer-related NTPase; nucleoside-triphosphatase C1orf57; nucleoside triphosphate phosphohydrolase;
SCAND2
SCAN domain containing 2 pseudogene
SCAN domain containing 2 pseudogene; SCAN domain containing 2; SCAN domain-containing 2;
ZKSCAN3
zinc finger with KRAB and SCAN domains 3
ZKSCAN3; zinc finger with KRAB and SCAN domains 3; zinc finger protein 306 , zinc finger protein 309 , ZNF306, ZNF309; zinc finger protein with KRAB and SCAN domains 3; dJ874C20.1; ZF47; Zfp47; mszf35; SCAN-KRAB-zinc finger protein; Skz1; Zfp-47; ZFP306; Zfp307; Zinc finger and SCAN domain containing protein 13; Zinc finger and SCAN domain-containing protein 13; Zinc finger protein 306; Zinc finger protein 306, isoform CRA_a; Zinc finger protein 307; Zinc finger protein 309; Zinc finger protein 47 homolog; Zinc finger protein with KRAB and SCAN domains3; Zinc finger protein zfp47; ZKSC3_HUMAN; ZNF309; ZSCAN13; OTTHUMP00000016204; ZNF306; dJ874C20.1.;
ZKSCAN4
zinc finger with KRAB and SCAN domains 4
ZKSCAN4; zinc finger with KRAB and SCAN domains 4; zinc finger protein 307 , zinc finger protein 427 , ZNF307, ZNF427; zinc finger protein with KRAB and SCAN domains 4; FLJ32136; P1P373C6; p373c6.1; p373c6.1 (novel C2H2 type zinc finger protein); Zinc finger protein 307; Zinc finger protein 427; ZKSC4_HUMAN; ZNF307; ZNF427;
ZSCAN1
zinc finger and SCAN domain containing 1
ZSCAN1; zinc finger and SCAN domain containing 1; zinc finger with SCAN domain 1; zinc finger and SCAN domain-containing protein 1; FLJ33779; ZNF915; MGC104472; MZF 1; MZF-1;
ZSCAN12
zinc finger and SCAN domain containing 12
ZSCAN12; zinc finger and SCAN domain containing 12; zinc finger protein 96 , zinc finger protein 305 , ZNF96, ZNF305; zinc finger and SCAN domain-containing protein 12; dJ29K1.2; KIAA0426; ZFP96; ZNF29K1; OTTHUMP00000016205; Zinc finger and SCAN domain containing protein 12; Zinc finger protein 305; Zinc finger protein 96; ZNF305; ZNF96;
ZSCAN16
zinc finger and SCAN domain containing 16
ZSCAN16; zinc finger and SCAN domain containing 16; zinc finger protein 392 , zinc finger protein 435 , ZNF392, ZNF435; zinc finger and SCAN domain-containing protein 16; dJ265C24.3; FLJ22191; Zinc finger and SCAN domain containing protein 16; Zinc finger protein 392; Zinc finger protein 435; ZNF392; ZNF435;
ZSCAN29
zinc finger and SCAN domain containing 29
ZSCAN29; zinc finger and SCAN domain containing 29; zinc finger protein 690 , ZNF690; zinc finger and SCAN domain-containing protein 29; FLJ35867; Zfp690; zinc finger protein 690; KOX31-like zinc finger protein; ZNF690; MGC129894; MGC129895;
CPXCR1
CPX chromosome region, candidate 1
CPXCR1; CPX chromosome region, candidate 1; CPX chromosomal region candidate gene 1 protein; cancer/testis antigen 77; CT77; CPX candidate region 1 protein; CPX chromosomal region candidate gene 1 protein homolog; Gm1143; hypothetical protein LOC53336; OTTHUMP00000023634; OTTHUMP00000023635; RP23-18E5.1;
HSPG2
heparan sulfate proteoglycan 2
HSPG2; heparan sulfate proteoglycan 2; Schwartz Jampel syndrome 1 (chondrodystrophic myotonia) , SJS1; basement membrane-specific heparan sulfate proteoglycan core protein; perlecan; perlecan proteoglycan; PRCAN; endorepellin (domain V region); PLC; SJA;
NCAN
neurocan
NCAN; neurocan; chondroitin sulfate proteoglycan 3 , CSPG3; neurocan core protein; neurocan proteoglycan; chondroitin sulfate proteoglycan 3 (neurocan); CSPG3; FLJ44681;
PODN
podocan
PODN; podocan; MGC24995; PCAN; podocan proteoglycan; SLRR5A; 9430070G18; LRRGT00160; RP23 40G2.7; OTTHUMP00000010487; OTTHUMP00000035906;
PRG2
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
PRG2; proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein); MBP; BMPG; MBP1; bone marrow proteoglycan; bone-marrow proteoglycan; proteoglycan 2 preproprotein; natural killer cell activator; eosinophil major basic protein; eosinophil granule major basic protein; prg-2; Piwi (fruitfly) Related Gene; Piwi (fruitfly) Related Gene family member (prg-2); 4H292; tag-292;
SDCCAG8
serologically defined colon cancer antigen 8
SDCCAG8; serologically defined colon cancer antigen 8; BBS16; CCCAP; NPHP10; NY CO 8; SLSN7; Antigen NY CO 8; Centrosomal colon cancer autoantigen protein; HSPC085; NPHP10 gene; NY-CO-8; Serologically defined colon cancer antigen 8 homolog; SLSN7 gene; antigen NY-CO-8; hCCCAP;
TUSC1
tumor suppressor candidate 1
TUSC1; tumor suppressor candidate 1; tumor suppressor candidate gene 1 protein; TSG 9; MGC131751; TSG9; TSG-9;
AGL
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
AGL; amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase; amylo 1, 6 glucosidase, 4 alpha glucanotransferase; glycogen debranching enzyme; glycogen storage disease type III; 9430004C13Rik; 9630046L06Rik; AI850929; C77197; 1110061O17Rik; Amylo 1 6 glucosidase 4 alpha glucanotransferase; GDE; Glycogen debrancher; amylo-1, 6-glucosidase, 4-alpha-glucanotransferase;
ALS2CR11
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11
ALS2CR11; amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11; amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein; FLJ25351; Amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 11; FLJ40332;
BRMS1L
breast cancer metastasis-suppressor 1-like
BRMS1L; breast cancer metastasis-suppressor 1-like; breast cancer metastasis suppressor 1 , BRMS1; breast cancer metastasis-suppressor 1-like protein; FLJ39177; MGC11296; breast cancer metastasis suppressor 1 like; BRM1L_HUMAN; BRMS1 homolog protein p40; BRMS1 like protein p40; BRMS1-homolog protein p40; BRMS1-like protein p40; BRMS1;
AUTS2
autism susceptibility candidate 2
AUTS2; autism susceptibility candidate 2; autism susceptibility gene 2 protein; FBRSL2; KIAA0442; autism-related protein 1; MGC13140;
BCAN
brevican
BCAN; brevican; brevican core protein; BEHAB; brevican proteoglycan; chondroitin sulfate proteoglycan 7; CSPG7; MGC13038; Brain enriched hyaluronan binding protein; Brevican core protein isoform 1; Brevican core protein isoform 2; Chondroitin sulfate proteoglycan BEHAB; brain-enriched hyaluronan-binding protein;
CAGE1
cancer antigen 1
CAGE1; cancer antigen 1; cancer/testis antigen 3 , CTAG3; cancer-associated gene 1 protein; bA69L16.7; cancer/testis antigen 95; CT95; cancer/testis antigen 3; cancer/testis antigen gene 1; CT3; CTAG3; FLJ40441;
CECR2
cat eye syndrome chromosome region, candidate 2
CECR2; cat eye syndrome chromosome region, candidate 2; cat eye syndrome critical region protein 2; KIAA1740;
NTPCR
nucleoside-triphosphatase, cancer-related
C1orf57; FLJ11383; MGC13186; HCR-NTPase; RP4-659I19.2; RP4-678E16.2; cancer-related nucleoside-triphosphatase; OTTHUMP00000035941; OTTHUMP00000035942; human cancer-related NTPase; nucleoside-triphosphatase C1orf57; nucleoside triphosphate phosphohydrolase;
CECR6
cat eye syndrome chromosome region, candidate 6
CECR6; cat eye syndrome chromosome region, candidate 6; cat eye syndrome critical region protein 6; AW048664; Cat eye syndrome chromosome region candidate 6; Cat eye syndrome chromosome region candidate 6 homolog (human); Cat eye syndrome chromosome region candidate 6 homolog; RGD1565302;
CASC4
cancer susceptibility candidate 4
CASC4; cancer susceptibility candidate 4; protein CASC4; DKFZp459F1927; H63; Cancer susceptibility candidate gene 4 protein; CASC4_HUMAN; Gene associated with HER-2/neu overexpression; MGC74708;
CASC5
cancer susceptibility candidate 5
CASC5; cancer susceptibility candidate 5; protein CASC5; AF15Q14; blinkin; bub linking kinetochore protein; cancer/testis antigen 29; CT29; D40; hKNL 1; hSpc105; kinetochore null 1 homolog (C. elegans); KNL1; PPP1R55; protein phosphatase 1; regulatory sub;
CECR5
cat eye syndrome chromosome region, candidate 5
CECR5; cat eye syndrome chromosome region, candidate 5; cat eye syndrome critical region protein 5;
CNRIP1
cannabinoid receptor interacting protein 1
CNRIP1; cannabinoid receptor interacting protein 1; CB1 cannabinoid receptor-interacting protein 1; CRIP-1; C2orf32; AI854501; RP23-348N2.3; 1500041B16Rik; 3110054C06Rik; 5330437A18Rik;
DLC1
deleted in liver cancer 1
DLC1; deleted in liver cancer 1; rho GTPase-activating protein 7; ARHGAP7; DLC 1; HP; p122 RhoGAP; StAR related lipid transfer (START) domain containing 12; STARD12; Rho-GTPase-activating protein 7; deleted in liver cancer 1 protein; START domain-containing protein 12; deleted in liver cancer 1 variant 2; rho-type GTPase-activating protein 7; StAR-related lipid transfer (START) domain containing 12; p122-RhoGAP; FLJ21120;
CNPY2
canopy 2 homolog (zebrafish)
CNPY2; canopy 2 homolog (zebrafish); TMEM4, transmembrane protein 4; protein canopy homolog 2; HP10390; ZSIG9; transmembrane protein 4; putative secreted protein Zsig9; MIR-interacting saposin-like protein; MSAP; TMEM4;
CT45A3
cancer/testis antigen family 45, member A3
CT45A3; cancer/testis antigen family 45, member A3; cancer/testis antigen family 45 member A3; cancer/testis antigen CT45 3; CT45 3; CT45.3; Cancer/testis antigen 45-3; Cancer/testis antigen 45A3; CT453_HUMAN; cancer/testis antigen CT45-3; CT45-3; RP13-36C9.1; RP13-36C9.3;
CT45A4
cancer/testis antigen family 45, member A4
CT45A4; cancer/testis antigen family 45, member A4; cancer/testis antigen family 45 member A4/A6; cancer/testis antigen CT45 4; CT45 4; CT45.4; Cancer/testis antigen 45-4/6; Cancer/testis antigen 45A4/45A6; CT45-4; CT454_HUMAN; CT45A6; cancer/testis antigen CT45-4;
DBC1
deleted in bladder cancer 1
DBC1; deleted in bladder cancer 1; DBCCR1, deleted in bladder cancer chromosome region candidate 1; deleted in bladder cancer protein 1; FAM5A; deleted in bladder cancer chromosome region candidate 1; bA574M5.1 (deleted in bladder cancer chromosome regio;
HAPLN3
hyaluronan and proteoglycan link protein 3
HAPLN3; hyaluronan and proteoglycan link protein 3; EXLD1, extracellular link domain containing, 1; HsT19883; EXLD1; Extracellular link domain containing, 1;
HIC2
hypermethylated in cancer 2
HIC2; hypermethylated in cancer 2; hypermethylated in cancer 2 protein; HRG22; KIAA1020; ZBTB30; ZNF907; HIC1-related gene on chromosome 22; Hic3; Zinc finger and BTB domain-containing protein 30; hic-2; hic-3; HIC1-related gene on chromosome 22 protein;
KERA
keratocan
KERA; keratocan; CNA2; keratocan proteoglycan; SLRR2B; KERA_HUMAN; Keratan sulfate proteoglycan keratocan; KTN;
LEPREL2
leprecan-like 2
LEPREL2; leprecan-like 2; prolyl 3-hydroxylase 3; GRCB; HSU47926; P3H3; prolyl 3 hydroxylase 3; B protein; protein B; gene rich cluster, B; leprecan-like 2 protein; leprecan-like protein 2;
LDOC1L
leucine zipper, down-regulated in cancer 1-like
LDOC1L; leucine zipper, down-regulated in cancer 1-like; protein LDOC1L; dJ1033E15.2; DKFZp761O17121; Mar6; Mart6; mammalian retrotransposon-derived protein 6; leucine zipper protein down-regulated in cancer cells-like;
LYSMD2
LysM, putative peptidoglycan-binding, domain containing 2
LYSMD2; LysM, putative peptidoglycan-binding, domain containing 2; lysM and putative peptidoglycan-binding domain-containing protein 2; MGC35274; DKFZp686I2243; LysM and putative peptidoglycan binding domain containing protein 2; OTTHUMP00000162616;
LYSMD4
LysM, putative peptidoglycan-binding, domain containing 4
LYSMD4; LysM, putative peptidoglycan-binding, domain containing 4; lysM and putative peptidoglycan-binding domain-containing protein 4; FLJ33008; LysM putative peptidoglycan binding domain containing 4; MGC99501;
ZSCAN5D
zinc finger and SCAN domain containing 5D
ZSCAN5D; zinc finger and SCAN domain containing 5D; putative zinc finger and SCAN domain-containing protein 5D; ZNF495D; hypothetical protein LOC646698; similar to hCG92381; similar to zinc finger and SCAN domain containing 5;
MTUS2
microtubule associated tumor suppressor candidate 2
MTUS2; microtubule associated tumor suppressor candidate 2; KIAA0774; microtubule-associated tumor suppressor candidate 2; +TIP of 150 kDa; cardiac zipper protein; CAZIP; TIP150; AU067634; C130038G02Rik; Gm763; mKIAA0774; 5730592G18Rik; A730013O20Rik; Microtubule plus-end tracking protein TIP150; MTUS2_HUMAN; OTTHUMP00000018187; OTTHUMP00000018188; RP11-274A8.2; Tracking protein of 150 kDa;
NUP214
nucleoporin 214kDa
NUP214; nucleoporin 214kDa; nucleoporin 214kD (CAIN); nuclear pore complex protein Nup214; CAIN; CAN; CAN protein; putative oncogene; D9S46E; N214; 214 kDa nucleoporin; NU214_HUMAN; Nucleoporin Nup214; Protein CAN; p250; CAN protein, putative oncogene;
CASC3
cancer susceptibility candidate 3
CASC3; cancer susceptibility candidate 3; protein CASC3; BTZ; MLN51; Barentsz; Barentsz protein; Cancer susceptibility candidate gene 3 protein; CASC3_HUMAN; Metastatic lymph node 51; Metastatic lymph node gene 51 protein; Metastatic lymph node protein 51; MLN 51; MLN 51 protein; Protein barentsz; Protein MLN 51;
ORAOV1
oral cancer overexpressed 1
ORAOV1; oral cancer overexpressed 1; oral cancer-overexpressed protein 1; oral cancer overexpressed protein 1 A; TAOS1; ORAOV1 oral cancer overexpressed 1; Tumor amplified and overexpressed sequence 1; oral cancer overexpressed protein 1-A; tumor-amplified and overexpressed sequence 1;
PCNX
pecanex homolog (Drosophila)
PCNX; pecanex homolog (Drosophila); PCNXL1, pecanex like 1 (Drosophila); pecanex-like protein 1; KIAA0805; KIAA0995; PCNXL1; Pecanex homolog; Pecanex like protein 1; pecanex-like 1;
OVCA2
OVCA2 ovarian tumor suppressor candidate 2
OVCA2; ovarian tumor suppressor candidate 2; ovarian cancer-associated gene 2 protein; candidate tumor suppressor in ovarian cancer 2; ovarian cancer gene-2 protein;
PBOV1
prostate and breast cancer overexpressed 1
PBOV1; prostate and breast cancer overexpressed 1; prostate and breast cancer overexpressed gene 1 protein; UC28; UROC28; PBOV 1; dJ171N11.2;
PIGK
phosphatidylinositol glycan anchor biosynthesis, class K
PIGK; phosphatidylinositol glycan anchor biosynthesis, class K; phosphatidylinositol glycan, class K; GPI-anchor transamidase; GPI transamidase subunit; GPI8; hGPI8; PIG-K; GPI8 homolog; phosphatidylinositol-glycan biosynthesis class K protein; MGC22559;
PIGN
phosphatidylinositol glycan anchor biosynthesis, class N
PIGN; phosphatidylinositol glycan anchor biosynthesis, class N; phosphatidylinositol glycan, class N; GPI ethanolamine phosphate transferase 1; MDC4; PIG N; MCD4 homolog; phosphatidylinositol-glycan biosynthesis class N protein; MCD4; MCAHS; PIG-N; MCAHS1;
PIGA
phosphatidylinositol glycan anchor biosynthesis, class A
PIGA; phosphatidylinositol glycan anchor biosynthesis, class A; GPI3; PIG-A; MCAHS2; phosphatidylinositol N-acetylglucosaminyltransferase subunit A; GPI anchor biosynthesis; GLCNAC-PI synthesis protein; class A GlcNAc-inositol phospholipid assembly protein; phosphatidylinositol-glycan biosynthesis, class A protein;
PIGX
phosphatidylinositol glycan anchor biosynthesis, class X
PIGX; phosphatidylinositol glycan anchor biosynthesis, class X; phosphatidylinositol glycan, class X; phosphatidylinositol-glycan biosynthesis class X protein; FLJ20522; PIG-X; GPI-mannosyltransferase subunit;
PIGY
phosphatidylinositol glycan anchor biosynthesis, class Y
PIGY; phosphatidylinositol glycan anchor biosynthesis, class Y; phosphatidylinositol glycan, class Y; protein preY, mitochondrial; MGC14156; phosphatidylinositol-glycan biosynthesis class Y protein; phosphatidylinositol N-acetylglucosaminyltransferase sub;
PRAC
prostate cancer susceptibility candidate
PRAC; prostate cancer susceptibility candidate; C17orf92, chromosome 17 open reading frame 92; small nuclear protein PRAC; prostate; rectum and colon; prostate, rectum and colon expressed gene protein; C17orf92; MGC32520;
PSORS1C1
psoriasis susceptibility 1 candidate 1
PSORS1C1; psoriasis susceptibility 1 candidate 1; C6orf16, chromosome 6 open reading frame 16; SEEK1; C6orf16; CHROMOSOME 6 OPEN READING FRAME 16; Protein SEEK1; PS1C1_HUMAN; Psoriasis susceptibility 1 candidate gene 1 protein; PSORS1 CANDIDATE GENE 1;
PSORS1C2
psoriasis susceptibility 1 candidate 2
PSORS1C2; psoriasis susceptibility 1 candidate 2; psoriasis susceptibility 1 candidate gene 2 protein; C6orf17; CHROMOSOME 6 OPEN READING FRAME 17; PSORS1 CANDIDATE GENE 2; SPR1;
SCAI
suppressor of cancer cell invasion
SCAI; suppressor of cancer cell invasion; C9orf126, chromosome 9 open reading frame 126; protein SCAI; FLJ36664; NET40; C9orf126; FLJ11758; MGC120525; MGC120526; MGC120528; SCAI_HUMAN; Suppressor of cancer cell invasion protein;
SCAND3
SCAN domain containing 3
SCAND3; SCAN domain containing 3; zinc finger protein 305 pseudogene 2 , zinc finger protein 452 , ZNF305P2, ZNF452; SCAN domain-containing protein 3; FLJ31087; KIAA1925; ZFP38 L; zinc finger protein 452; zinc finger protein 305 pseudogene 2; dJ1186N24.3;
SMCR7
Smith-Magenis syndrome chromosome region, candidate 7
SMCR7; Smith-Magenis syndrome chromosome region, candidate 7; mitochondrial dynamic protein MID49; MGC23130; MiD49; mitochondrial dynamic protein of 49 kDa; Smith-Magenis syndrome chromosomal region candidate gene 7 protein;
SPOCK1
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
SPOCK1; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1; sparc/osteonectin, cwcv and kazal like domains proteoglycan (testican) , SPOCK, TIC1; testican-1; testican 1; Sparc/osteonectin, cwcv and kazal like domains proteoglycan 1; SPOCK; TIC1; TICN1; TESTICAN;
CNPY3
canopy 3 homolog (zebrafish)
CNPY3; canopy 3 homolog (zebrafish); TNRC5, trinucleotide repeat containing 5; protein canopy homolog 3; CAG4A; CAG repeat containing; CTG repeat protein 4a; protein associated with TLR4; expanded repeat domain, CAG/CTG 5; trinucleotide repeat containing;
SPOCK2
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
SPOCK2; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2; testican-2; KIAA0275; testican 2; and Kazal-like domains proteoglycan 2; CWCV; FLJ97039; SPARC/osteonectin; Sparc/osteonectin cwcv and kazal like domains proteoglycan (testican) 2; Sparc/osteonectin cwcv and kazal like domains proteoglycan 2; SPOCK 2; Testican2; TICN 2; TICN2; TICN2_HUMAN; SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2;
SDC3
syndecan 3
SDC3; syndecan 3; SDCN; SYND3; syndecan-3; N-syndecan; syndecan neural type; syndecan proteoglycan 3;
UROC1
urocanase domain containing 1
UROC1; urocanase domain containing 1; urocanate hydratase; FLJ31300; HMFN0320; HUTU_HUMAN; Imidazolonepropionate hydrolase; MGC135007; MGC135008; Urocanase;
ZSCAN30
zinc finger and SCAN domain containing 30
ZSCAN30; zinc finger and SCAN domain containing 30; zinc finger protein 397 opposite strand , ZNF397 opposite strand , ZNF397OS; zinc finger and SCAN domain-containing protein 30; ZNF917; ZNF-WYM; ZNF397 opposite strand; zinc finger protein 397OS; zinc f;
TSKU
tsukushi small leucine rich proteoglycan homolog (Xenopus laevis)
TSKU; tsukushi small leucine rich proteoglycan homolog (Xenopus laevis); leucine rich repeat containing 54 , LRRC54, tsukushin; tsukushin; E2IG4; TSK; E2 induced gene 4 protein; Leucine rich repeat containing protein 54; LRRC54; Tsukushi; tsukushi homolog; E2-induced gene 4 protein; leucine rich repeat containing 54; leucine-rich repeat-containing protein 54; tsukushi, small leucine rich proteoglycan;
TUSC5
tumor suppressor candidate 5
TUSC5; tumor suppressor candidate 5; IFITMD3; interferon induced transmembrane protein domain containing 3; located at seventeen p thirteen point three 1; LOST1; Protein located at seventeen p thirteen point three 1; protein located at seventeen-p-thirteen point three 1; interferon-induced transmembrane domain-containing protein D3;
TUSC2
tumor suppressor candidate 2
TUSC2; tumor suppressor candidate 2; PDAP2, PDGFA associated protein 2; C3orf11; FUS1; PAP; Fusion 1 protein; PDAP2; PDGFA associated protein 2; TUSC 2; fus-1 protein; PDGFA-associated protein 2;
ZSCAN10
zinc finger and SCAN domain containing 10
ZSCAN10; zinc finger and SCAN domain containing 10; ZNF206; zinc finger and SCAN domain-containing protein 10; zinc finger protein 206;
ZKSCAN2
zinc finger with KRAB and SCAN domains 2
ZKSCAN2; zinc finger with KRAB and SCAN domains 2; zinc finger protein 694 , ZNF694; zinc finger protein with KRAB and SCAN domains 2; FLJ23199; Zinc finger protein 694; ZKSC2_HUMAN; zinc finger and SCAN domain containing 31; ZNF694; ZSCAN31;
ZKSCAN14
zinc finger with KRAB and SCAN domains 14
ZKSCAN14; zinc finger with KRAB and SCAN domains 14; zinc finger protein 394; Zinc finger protein with KRAB and SCAN domains 14; ZN394_HUMAN; Znf394; zfp-94; zinc finger protein 94; zinc finger protein 99; Zfp99; 2310046C23Rik; 2810437E14Rik;
ZSCAN5A
zinc finger and SCAN domain containing 5A
ZSCAN5A; zinc finger and SCAN domain containing 5A; zinc finger and SCAN domain containing 5 , zinc finger protein 495 , ZNF495, ZSCAN5; zinc finger and SCAN domain-containing protein 5A; MGC4161; Zinc finger and SCAN domain containing protein 5; Zinc finger protein 495; ZNF495; zinc finger and SCAN domain containing 5; ZSCAN5;
IMPG1
interphotoreceptor matrix proteoglycan 1
IMPG1; interphotoreceptor matrix proteoglycan 1; sialoprotein associated with cones and rods , SPACR; GP147; IPM150; IMPG1_HUMAN; Interphotoreceptor matrix proteoglycan of 150 kDa; IPM-150; Sialoprotein associated with cones and rods; SPACR;
MACC1
metastasis associated in colon cancer 1
MACC1; metastasis associated in colon cancer 1; metastasis-associated in colon cancer protein 1; 7A5; SH3BP4L; putative binding protein 7a5; SH3 domain-containing protein 7a5;
PIGW
phosphatidylinositol glycan anchor biosynthesis, class W
PIGW; phosphatidylinositol glycan anchor biosynthesis, class W; phosphatidylinositol glycan, class W; phosphatidylinositol-glycan biosynthesis class W protein; FLJ37433; Gwt1; PIG-W; PIGW_HUMAN;
SDCCAG3
serologically defined colon cancer antigen 3
SDCCAG3; serologically defined colon cancer antigen 3; NY CO 3; antigen NY-CO-3; NY-CO-3;
VOPP1
vesicular, overexpressed in cancer, prosurvival protein 1
VOPP1; vesicular, overexpressed in cancer, prosurvival protein 1; DKFZp564K0822; ECop; EGFR coamplified and overexpressed protein; FLJ20532; GASP; Glioblastoma amplified secreted protein; Glioblastoma-amplified secreted protein; EGFR-coamplified and overe;
Gpc2
glypican 2 (cerebroglycan)
GPC2;glypican 2 (cerebroglycan);cerebroglycan;DKFZp547M109;FLJ38962;glypican proteoglycan 2;cerebroglycan proteoglycan;Q8N158;
C. albicans
Candida albicans
C albicans; C. albicans; Thrush; Saccharomycotina; Ascomycota; Saccharomycetales; Saccharomycetaceae; Candida albicans; Candida;
PG-PS 10S
Peptidoglycan-Polysaccharide
PG-PS 10S; PG-PS 10S (group A streptococcus); Peptidoglycan-Polysaccharide;
PG-PS 100P
Peptidoglycan-Polysaccharide
PG-PS 100P; peptidoglycan-polysaccharide of group A streptococcus; peptidoglycan;
LYSMD1
LysM, putative peptidoglycan-binding, domain containing 1
LYSMD1;LysM, putative peptidoglycan-binding, domain containing 1;32070;ENSG00000163155;SB145;RP11-68I18.5;1q21.3;MGC35223;lysM and putative peptidoglycan-binding domain-containing protein 1;lysM and putative peptidoglycan-binding domain-containing protein 1;
LYSMD3
LysM, putative peptidoglycan-binding, domain containing 3
LYSMD3;LysM, putative peptidoglycan-binding, domain containing 3;26969;ENSG00000176018;5q14.3;FLJ13542, DKFZp686F0735;lysM and putative peptidoglycan-binding domain-containing protein 3;lysM and putative peptidoglycan-binding domain-containing protein 3;
NGLY1
N-glycanase 1
NGLY1;N-glycanase 1;17646;ENSG00000151092;PNG1;PNGase;3p24.2;FLJ11005, FLJ12409;peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase;peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase;hPNGase;peptide:N-glycanase;EC 3.5.1.52;
PCNXL2
pecanex-like 2 (Drosophila)
PCNXL2;pecanex-like 2 (Drosophila);8736;ENSG00000135749;1q42.2;FLJ11383, KIAA0435;pecanex-like protein 2;pecanex-like protein 2;
PCNXL3
pecanex-like 3 (Drosophila)
PCNXL3;pecanex-like 3 (Drosophila);18760;ENSG00000197136;11q13.1;FLJ22427;pecanex-like protein 3;pecanex-like protein 3;
PIGG
phosphatidylinositol glycan anchor biosynthesis, class G
PIGG;phosphatidylinositol glycan anchor biosynthesis, class G;25985;ENSG00000174227;GPI7;LAS21;PRO4405;RLGS1930;4p16.3;FLJ20265, FLJ39925, MGC131903, DKFZp434A1810, DKFZp434C1712, DKFZp434M1131;GPI ethanolamine phosphate transferase 2;GPI ethanolamine phosphate transferase 2;PIG-G;hGPI7;GPI7 homolog;phosphatidylinositol glycan, class G;phosphatidylinositol-glycan biosynthesis class G protein;
SMCR8
Smith-Magenis syndrome chromosome region, candidate 8
SMCR8;Smith-Magenis syndrome chromosome region, candidate 8;17921;ENSG00000176994;17p11.2;FLJ34716, FLJ60657;Smith-Magenis syndrome chromosomal region candidate gene 8 protein;Smith-Magenis syndrome chromosomal region candidate gene 8 protein;
ZSCAN2
zinc finger and SCAN domain containing 2
ZSCAN2;zinc finger and SCAN domain containing 2;20994;ENSG00000176371;ZFP29;ZNF854;15q25.2;FLJ20595;zinc finger and SCAN domain-containing protein 2;zinc finger and SCAN domain-containing protein 2;zfp-29;zinc finger protein 854;zinc finger protein 29 homolog;
ZSCAN23
zinc finger and SCAN domain containing 23
ZSCAN23;zinc finger and SCAN domain containing 23;21193;ENSG00000187987;ZNF390;ZNF453;dJ29K1.3;dJ29K1.3.1;6p22.1;FLJ99276, MGC126606, MGC126608;zinc finger and SCAN domain-containing protein 23;zinc finger and SCAN domain-containing protein 23;zinc finger protein 390;zinc finger protein 453;
CNPY4
canopy 4 homolog (zebrafish)
CNPY4;canopy 4 homolog (zebrafish);28631;ENSG00000166997;PRAT4B;7q22.1;MGC40499;protein canopy homolog 4;protein canopy homolog 4;PRotein Associated with Tlr4;
HAPLN2
hyaluronan and proteoglycan link protein 2
HAPLN2;hyaluronan and proteoglycan link protein 2;17410;ENSG00000132702;BRAL1;1q23.1;hyaluronan and proteoglycan link protein 2;hyaluronan and proteoglycan link protein 2;brain link protein 1;brain link protein-1;
CASC1
cancer susceptibility candidate 1
CASC1;cancer susceptibility candidate 1;29599;ENSG00000118307;LAS1;PPP1R54;12p12.1;FLJ10921;cancer susceptibility candidate protein 1;cancer susceptibility candidate protein 1;lung adenoma susceptibility 1-like protein;protein phosphatase 1, regulatory subunit 54;
CNPY1
canopy1
CNPY1;canopy1;ENSDARG00000003757;chromosome: 2;protein canopy-1;protein canopy-1;D121 protein;EC 3.6.5.4;
EPYC
epiphycan
EPYC; epiphycan; 3053; ENSG00000083782; PGLB; DSPG3; Pg-Lb; SLRR3B; 12q21; proteoglycan-lb; epiphycan proteoglycan; dermatan sulfate proteoglycan 3; small chondroitin/dermatan sulfate proteoglycan; dermatan sulphate proteoglycan 3;
Blcap
BLCAP bladder cancer associated protein [ Homo sapiens ]
Bc10; Bladder cancer 10 kDa protein; Bladder cancer related protein (10kD); Bladder cancer-associated protein; BLCAP; BLCAP_HUMAN; bladder cancer associated protein;
CA 19-9
Cancer Antigen 19-9
CA19-9; carbohydrate antigen 19-9; cancer antigen 19-9; sialylated Lewis (a) antigen); Sialyl Lewis (a); Sialyl Lewisa;
An Approved Malarial Drug is Promising for Preventing and Stopping Breast Cancer
Explore New Aspects from Old ItemsChloroquine During a clinical trial, researchers of Mason Center unexpectedly found a malarial drugChloroquine can stop the precursor cells of breast cancer, which brings hope and new thoughts for patients and doctors. Thus they launch a PINC (Preventing Invasiv...
Can Diabetes Drug be used to treat Brain Cancer?
Metformin Vs Glioblastoma On Nov. 15, a research finding was published on the STEM CELLS Translational Medicine. It suggests a new treatment path for glioblastoma, a highly aggressive, deadly malignancy with very short median survival period after diagnosis. They found a protein that stops stem ...
Two proteins, ATG12 and ATG5 Might Help People Developing Innovative Cancer Therapies
Scientists at The Scripps Research Institute (TSRI) have found two key subunits within a cell that helps maintaining cell health. They identified how the two proteins help create organelles. Their discoveries make people think about interfering with the formation of these organelles and lead to new ...
Nature: No Haploid Phase in Candida Albicans
Candida albicansis adiploidfungusthat grows both as yeastandfilamentouscells. It is also a causal agent ofopportunisticoralandgenitalinfections in humans. It has high mortality with 45 percent and is one of the four main microbial pathogens in hospital acquired infections. However, the treatment...
The Role of Protein SFRP2 on Human Cancers and New Clue for Drug Development
When researchers tried to find an alternative to the anti-tumor drugAvastin (bevacizumab) that target on VEGF to inhibit angiogenesis, they found more roles of SFRP2, especially as a stimulator of angiogenesis. Protein SFRP2, secreted frizzed-related protein 2, according to the previous ...
Stat5 Protein is an Important Target for the Research of Prostate Cancer
Among many factors that affect prostate cancer, Stat5 is one of the important. As early as in 2003, scientists have discovered that Stat5 protein is critical for viability of prostate cancer cells and growth of prostate tumors in mice. In 2005, researchers demonstrated that Stat5 activity was assoc...
CD44, CD47 and MET Have been Found Related to Initiation of Metastatic Cancer Cells
Circulating tumor cells (CTCs) are now treated as a biomarker for prognosis and people think the CTCs are connected to cancer metastasis. But there is no clear clue to clarify how CTCs affect patients. Some scientists thought only few CTCs will form secondary tumor in different organs as the metast...
Novel Method for Detection of Ovarian Cancer Might Launch Soon
Ovarian cancer is considered to be the most difficult to detect in kinds of cancers. It is difficult to note or detect at early cancer stage, if pain occurs, people might treat it as other symptoms as often been mistaken for other diseases. This makes cancer prevention and control very difficult. D...
DNA Methylation—the Hot “Candidate” of 2013 Nobel Prize
The annual Nobel Prize feast is approaching and the whole science field is eager to celebrate laurels and DNA Methylation is one of the expected laurels. DNA methylation is a form of chemical modification of DNA. In the condition of non-DNA code change, it changes indiv...
Bladder Cancer-related Gene Mutation was Identified
The finding comes from an international research associated with bladder carcinoma-related gene mutation. In some way, the finding stresses the importance of genetic test for prevention. The research was later published on Nature Genetics. During the study, researchers f...
Drug Resistance Antibodies Speed Up Cancer Researches
Drug resistance could be a severe problem in the way of benefiting eventual health care. Drug resistance, also known as antimicrobial resistance, occurs when microorganisms (including bacteria, viruses, fungi and parasites) change in ways that render the medications used to cure the infection...
Fluorescent Cattle—Gives New Hope for Cancer Treatment
Do you drink milk every day? Does it pure or have some additives? We all know that manufacturers in dairy industry have thought about all kinds of ways to make their products attractive to their customers. But have you ever thought that there might be fluorescent cattle? Can you imagine what does it...
In Face of Pancreatic Cancer
Gene Database Associated with Pancreatic Cancer for Your Reference Whenever talk about pancreatic cancer, people would feel scared. In China, pancreatic cancer is called as the king of all cancers due to its poor prognosis and short survival time. In developed countries, it is also a very trouble...
Amgen Webcast Investor Meeting at Upcoming American Heart Association
Now one of our industry peersAmgen, according to the Market Capitalization in Q2 of 2012 rank, is the top 2/25 biotechnology companies, the world largest independent biotechnology firm, On Nov. 1, announced it will host a webcast investor meeting at the American Heart Association (AHA) Scientific ...
Garlic And Broccoli Were Found to Help Improve Cancer Treatment
Our immune system is developed to remove things that are alien to our bodies. However. Sometimes, some types of cancer cells contain mechanisms that block the immune systems ability to recognize them. And some stimulating molecules can over-activate the immune system and ...
The 2nd Anticancer Agents Congress: Targeting Cancer Stem Cell
When November 21 to 24th 2013 Where Belek, Antalya, Turkey (the congress hotel will be announced soon) Introduction Sponsored by EACR, the meeting aims to bring all kinds of anti-cancer agents researchers together and discuss recent achievements in the field of basic research on ...
Immunocore Cooperates with GlaxoSmithKline to Target on Cancer and Viral Disease
On July 9, 2013, Immunocore announced that it has entered into a partnership with GlaxoSmithKlinefor multiple novel targets after signing the research and licensing agreement to discover and develop novel biological drugsImmune mobilising mTCR Against Cancer (ImmTACs) in earlier times. ...
Collaboration between Bio Service Provider and Biotech Company on Biospecific Cancer Antibodies
On Jan. 14, 2013, OcellO B.V., providing drug discovery screening services with its 3D cell culture-based screening platform, and Merus B.V., a biotech company, like Creative BioMart , offering specific antibodies and recombinant antibodies to help research, have entered into collaboration....
